Iovance Biotherapeutics, Inc. · NASDAQ:IOVA
Vogt Frederick G exercised options for 41,668 Iovance Biotherapeutics, Inc. shares (Form 4)
Traded Jun 1, 2026 · Filed Jun 3, 2026
On Jun 1, 2026, Vogt Frederick G (Director, Interim CEO & General Counsel) exercised options for 41,668 Iovance Biotherapeutics, Inc. shares, leaving 553,505 shares. Filed Jun 3, 2026 (Form 4).
- Options exercised
- 41,668 shares
- Holding after
- 553,505 shares
- Trading plan
- No
- Role
- Director, Interim CEO & General Counsel
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 1, 2026 | Common Stock | Option exercise | 41,668 | 571,206 | Direct | |
| Jun 1, 2026 | Common Stock | Shares withheld for tax | 17,701 | US$3.96 | 553,505 | Direct |
Source
Related
- Iovance Biotherapeutics, Inc.
- Vogt Frederick G
- Iovance Biotherapeutics, Inc. shareholders
- Form 4 · Vogt Frederick G · Sep 10, 2026
- Form 4 · Vogt Frederick G · Sep 3, 2026
- Form 4 · Vogt Frederick G · Jun 9, 2026
- Form 4 · Bilinsky Igor · Sep 10, 2026
- Form 4 · Puri Raj K. · Sep 10, 2026
- Form 4 · Puri Raj K. · Sep 3, 2026
- Form 4 · Bilinsky Igor · Sep 3, 2026
- Form 4 · Kirby Daniel Gordon · Aug 12, 2026